Ledger.Open graph →

SEC Form D · filed January 7, 2025

LIPELLA PHARMACEUTICALS INC

Offering

$6.0M

Sold

$2.6M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

PITTSBURGH, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Daniel Cohen · Pittsburgh, PADirector Jonathan Kaufman · Pittsburgh, PAExec · Director Byong Kim · Pittsburgh, PADirector Ryan Pruchnic · Pittsburgh, PADirector Lori Birder · Pittsburgh, PADirector Michael Chancellor · Pittsburgh, PAExec · Director Naoki Yoshimura · Pittsburgh, PADirector Douglas Johnston · Pittsburgh, PAExec Jonathan Kaufman · Pittsburgh, PAExec · Director Naoki Yoshimura · Pittsburgh, PADirector Douglas Johnston · Pittsburgh, PAExec Byong Kim · Pittsburgh, PADirector Lori Birder · Pittsburgh, PADirector Ryan Pruchnic · Pittsburgh, PADirector Michael Chancellor · Pittsburgh, PAExec · Director Daniel Cohen · Pittsburgh, PADirector Todd Fein · RENO, NVExec Mark Watson · RENO, NVExec · Director Douglas Willmore · RENO, NVDirector Jeff Nuss · RENO, NVDirector Allan English · RENO, NVDirector Alexander Bhathal · Newport Beach, CADirector Chris Marsh · Newport Beach, CADirector Simon Henderson · VANCOUVER, British Columbia, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗